We are live on ! Find out more
MOR

MorphoSys AG American Depositary Shares

Delisted

MOR was delisted on the 2nd of August, 2024.

30 hedge funds and large institutions have $232M invested in MorphoSys AG American Depositary Shares in 2018 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 4

30% more funds holding

Funds holding: 2330 (+7)

7% less capital invested

Capital invested by funds: $250M → $232M (-$17.9M)

30% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 10

Holders
30
Holders Change
+7
Holders Change %
+30.43%
% of All Funds
0.67%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
11
Increased
7
Reduced
10
Closed
4
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$128M -$3.72M -141,696 -3%
RG
2
Redmile Group
California
$22.6M -$113K -4,300 -0.5%
TCM
3
TimesSquare Capital Management
New York
$18.5M -$1.74M -66,400 -8%
Franklin Resources
4
Franklin Resources
California
$16.9M -$5.95M -226,863 -25%
DM
5
Deerfield Management
New York
$15.2M
Massachusetts Financial Services
6
Massachusetts Financial Services
Massachusetts
$10.7M +$1.05M +39,951 +10%
Point72 Asset Management
7
Point72 Asset Management
Connecticut
$5.06M +$5.25M +200,000 New
Millennium Management
8
Millennium Management
New York
$4.45M -$3.45M -131,358 -43%
SEI Investments
9
SEI Investments
Pennsylvania
$2.05M
VIA
10
Vident Investment Advisory
Georgia
$1.44M -$661K -25,178 -31%
Alyeska Investment Group
11
Alyeska Investment Group
Illinois
$1.32M -$20.8K -791 -1%
SI
12
Sensato Investors
California
$790K +$820K +31,245 New
Marshall Wace
13
Marshall Wace
United Kingdom
$707K +$735K +28,006 New
Jane Street
14
Jane Street
New York
$683K +$291K +11,076 +70%
HJIM
15
Henry James International Management
New York
$575K +$597K +22,744 New
Envestnet Asset Management
16
Envestnet Asset Management
Illinois
$572K +$593K +22,594 New
Citadel Advisors
17
Citadel Advisors
Florida
$512K +$533K +20,299 New
Neuberger Berman Group
18
Neuberger Berman Group
New York
$505K +$525K +20,000 New
OMC
19
Old Mission Capital
Illinois
$504K +$229K +8,718 +78%
JP Morgan Chase
20
JP Morgan Chase
New York
$349K +$186K +7,087 +105%
ACM
21
Aquilo Capital Management
California
$298K +$70.8K +2,700 +30%
Two Sigma Investments
22
Two Sigma Investments
New York
$217K +$226K +8,608 New
Comerica Bank
23
Comerica Bank
Texas
$209K +$198K +7,543 New
AG
24
Advisor Group
Arizona
$108K +$106K +4,057 +1,803%
RCAG
25
Rehmann Capital Advisory Group
Michigan
$107K -$26.2K -997 -19%

MOR Hedge Fund Activity: Q4 2018 in Review

30 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in MorphoSys AG American Depositary Shares (MOR) for Q4 2018, worth a combined $232M — down 7.2% from $250M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new MOR positions and 4 closed out — a net gain of 7 holders — while 7 added to existing stakes and 10 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $5.25M. The largest seller was Franklin Resources, cutting an estimated $5.95M.

  • 30 institutional investors held MorphoSys AG American Depositary Shares (MOR) as of Q4 2018, up from 23 in Q3 2018.
  • Funds reported $232M of MorphoSys AG American Depositary Shares stock for Q4 2018, down 7.2% quarter-over-quarter.
  • 11 funds opened new MorphoSys AG American Depositary Shares positions in Q4 2018 and 4 closed out, a net change of +7 holders.
  • The largest MorphoSys AG American Depositary Shares buyer in Q4 2018 was Point72 Asset Management, an estimated $5.25M added.
  • The largest MorphoSys AG American Depositary Shares seller in Q4 2018 was Franklin Resources, an estimated $5.95M sold.

Based on aggregated 13F filings for Q4 2018.